• Recorded Webinar
  • On-Demand
  • Pediatrics
This webinar will present the newest content of the 2024 Pediatric Obesity Algorithm®.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Treatment Strategies
Join us for this webinar unveiling the 2024 edition of the Obesity Algorithm®. Dr. Justin Tondt will discuss the updates and enhancements incorporated into this latest iteration. 
  • 0.50 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Special Populations
Obesity is one of the leading causes of preventable death. Obesity-related increases metabolic and cardiovascular risk occur at a lower body mass index in Asian adults.
  • 0.50 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
  • Pediatrics
Is the intersection of Childhood Obesity and pediatric sleep problems merely confined to a discussion of poor sleep habits leading to weight gain?
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Obesity is one of the leading causes of the development of type 2 diabetes mellitus.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Insulin resistance (IR) is a common biochemical abnormality in patients with excess adiposity, obesity, and its complications.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Obesity is emerging as a serious and complex health condition affecting about 1 billion people in the world.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Nutrition Therapy
The number of non-nutritive sweeteners (NNS) available, both synthetic and natural, has increased rapidly in recent years.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Behavioral Modification
  • Pediatrics
Childhood obesity is a multifaceted health challenge.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Pediatrics
  • Pharmacotherapy
Obesity pharmacotherapy often is solely equated as therapeutic use of anti-obesity medications (AOMs). In this session, two important factors in obesity pharmacotherapy will be discussed.
  • 1.00 AMA PRA Category 1 Credit

Pages